Phase two clinical trial of combination oxaliplatin, irinotecan, and cetuximab for patients with locally advanced or metastatic pancreatic cancer.

被引：2
|
作者：
Abdou, Yara
Friend, Sarah Cooke
Patt, Yehuda Z.
Gan, Christine
Lee, Fa-Chyi
机构：
[1] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Albuquerque, NM 87131 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15781
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15781
引用
收藏
页数：6
相关论文
共 50 条
  • [11] OXALIPLATIN VERSUS IRINOTECAN IN COMBINATION TO CETUXIMAB FOR METASTATIC COLORECTAL CANCER. A SYSTEMATIC REVIEW WITH META-ANALYSIS
    Sasse, Andre Deeke
    Conceicao, Vinicius Correa
    ANNALS OF ONCOLOGY, 2011, 22 : v100 - v100
  • [12] Phase I trial of preoperative cetuximab in combination with oxaliplatin, capecitabine, and radiation therapy for locally advanced rectal cancer
    Cabebe, E. C.
    Kuo, T.
    Koong, A.
    Welton, M.
    Shelton, A.
    Kunz, P. L.
    Ford, J. M.
    Sikic, B. I.
    Kaiser, H. L.
    Rogers, J.
    Fisher, G. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [13] Preliminary results of a phase II trial of irinotecan (I) and gemcitabine (G) in patients with locally advanced or metastatic bladder cancer.
    Chaudhary, U
    Shannon, S
    Curry, N
    Keane, TE
    Means, RT
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S293 - S293
  • [14] EPIC:: Phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer
    Sobrero, Alberto F.
    Maurel, Joan
    Fehrenbacher, Louis
    Scheithauer, Werner
    Abubakr, Yousif A.
    Lutz, Manfred P.
    Vega-Villegas, M. Eugenia
    Eng, Cathy
    Steinhauer, Ernst U.
    Prausova, Jana
    Lenz, Heinz-Josef
    Borg, Christophe
    Middleton, Gary
    Kroening, Hendrik
    Luppi, Gabriele
    Kisker, Oliver
    Zubel, Angela
    Langer, Christiane
    Kopit, Justin
    Burris, Howard A., III
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) : 2311 - 2319
  • [15] Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer:: Results of a GERCOR and GISCAD phase III trial
    Louvet, C
    Labianca, R
    Hammel, P
    Lledo, G
    Zampino, MG
    André, T
    Zaniboni, A
    Ducreux, M
    Aitini, E
    Taïeb, J
    Faroux, R
    Lepere, C
    de Gramont, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3509 - 3516
  • [16] FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
    Faris, Jason Edward
    Hong, Theodore S.
    McDermott, Shaunagh
    Borger, Darrell R.
    Guimaraes, Alexander R.
    Wo, Jennifer Yon-Li
    Sahani, Dushyant
    Dias, Lauren Elizabeth
    Allen, Jill N.
    Zhu, Andrew X.
    Murphy, Janet E.
    Kwak, Eunice Lee
    Ryan, David P.
    Clark, Jeffrey W.
    Blaszkowsky, Lawrence Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [17] A pilot study of gemcitabine (g), oxaliplatin (o), cetuximab (c) for locally advanced or metastatic pancreatic cancer
    Merchan, J. R.
    Venkatraman, A.
    Macintyre, J.
    Ciombor, K.
    Levi, J.
    Ribeiro, A.
    Sleeman, D.
    Aurea, F.
    Vulfovich, M.
    Rocha-Lima, C. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [18] Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer
    Larsen, Finn Ole
    Pfeiffer, Per
    Nielsen, Dorte
    Skougaard, Kristin
    Qvortrup, Camilla
    Vistisen, Kirsten
    Fromm, Anne-Lene
    Jorgensen, Trine L.
    Bjerregaard, Jon K.
    Hoegdall, Estrid
    Jensen, Benny V.
    ACTA ONCOLOGICA, 2011, 50 (04) : 574 - 577
  • [19] Phase 1B study of vemurafenib in combination with irinotecan and cetuximab in patients with BRAF-mutated advanced cancers and metastatic colorectal cancer.
    Hong, David S.
    Morris, Van Karlyle
    Fu, Siqing
    Overman, Michael J.
    Piha-Paul, Sarina Anne
    Kee, Bryan K.
    Zinner, Ralph
    Fogelman, David R.
    Mistry, Reena
    Shureiqi, Imad
    Meric-Bernstam, Funda
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [20] Phase II trial of capecitabine and irinotecan in combination with concurrent radiotherapy for neoadjuvant treatment of locally advanced rectal cancer.
    Willeke, F
    Tiefenbacher, U
    Hochhaus, A
    Wenz, F
    von Gerstenbergk, B
    Gnad-Vogt, U
    Horisberger, K
    Post, S
    Hofheinz, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 268S - 268S
12345